CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?

Abstract

HomeCirculationVol. 145, No. 10CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine? No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextCYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine? Dimitri J. Maamari, MD, Farouc A. Jaffer, MD, PhD, Amit V. Khera, MD, MSc and Akl C. Fahed, MD, MPH Dimitri J. MaamariDimitri J. Maamari https://orcid.org/0000-0003-2797-9370 Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.). Search for more papers by this author , Farouc A. JafferFarouc A. Jaffer https://orcid.org/0000-0001-7980-384X Division of Cardiology (F.A.J., A.V.K., A.C.F.), Department of Medicine, Massachusetts General Hospital Cardiovascular Research Center, Cardiology Division (F.A.J., A.C.F.), Massachusetts General Hospital Department of Medicine, Harvard Medical School (F.A.J., A.V.K., A.C.F.) Boston. Search for more papers by this author , Amit V. KheraAmit V. Khera https://orcid.org/0000-0001-6535-5839 Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital Division of Cardiology (F.A.J., A.V.K., A.C.F.), Department of Medicine, Massachusetts General Hospital Department of Medicine, Harvard Medical School (F.A.J., A.V.K., A.C.F.) Boston. Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.). Search for more papers by this author and Akl C. FahedAkl C. Fahed Correspondence to: Akl C. Fahed, MD, MPH, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, CPZN 3.218, Boston, MA 02114. Email E-mail Address: [email protected] https://orcid.org/0000-0002-4849-6389 Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital Division of Cardiology (F.A.J., A.V.K., A.C.F.), Department of Medicine, Massachusetts General Hospital Cardiovascular Research Center, Cardiology Division (F.A.J., A.C.F.), Massachusetts General Hospital Department of Medicine, Harvard Medical School (F.A.J., A.V.K., A.C.F.) Boston. Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.). Search for more papers by this author Originally published7 Mar 2022https://doi.org/10.1161/CIRCULATIONAHA.121.057028Circulation. 2022;145:721–723FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 723.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Akl C. Fahed, MD, MPH, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, CPZN 3.218, Boston, MA 02114. Email [email protected]harvard.edu